Legal Opinion
Pfizer Inc. v. Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided April 15, 2004No. 03-1227, 03-1258PublishedCited by 12 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge NEWMAN. Dissenting opinion filed by Chief Judge MAYER.
PAULINE NEWMAN, Circuit Judge.
Pfizer Inc. appeals the judgment of the United States District Court for the District of New Jersey, ruling that defendants Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (together “Dr. Reddy’s”) do not infringe the extended term of Pfizer’s United States Patent No. 4,572,909 (“the '909 patent”), and on this ground dismissing the complaint.1 We conclude not only that the extended patent *1363term includes the claims that cover Dr. Reddy’s product, but…
2Cases cited4 opinions
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Glaxo, Inc., and Glaxo Group Limited v. Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1997
- Abbott Laboratories v. Frank D. Young, Dr., Commissioner, Food and Drug AdministrationCourt of Appeals for the D.C. Circuit · 1990
- Merck & Co. v. KesslerCourt of Appeals for the Federal Circuit · 1996
3Cited by12 opinions
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- In Re Omeprazole Patent LitigationDistrict Court, S.D. New York · 2007
- PHOTOCURE ASA v. KapposCourt of Appeals for the Federal Circuit · 2010
- Pharmaceutical Research & Manufacturers of America v. District of ColumbiaDistrict Court, District of Columbia · 2005
- PHOTOCURE ASA v. DudasDistrict Court, E.D. Virginia · 2009
7 more not listed; retrieve them via the Exa API.